Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, 309 East Second Street, Pomona, CA, 91766, USA.
BMC Neurosci. 2022 Jan 4;23(1):2. doi: 10.1186/s12868-021-00686-5.
Methamphetamine (MA) is a non-selective monoamine releaser and thus releases serotonin (5-HT), norepinephrine (NE) and dopamine (DA) from corresponding nerve terminals into synapses. DOI ((±)-2, 5-dimethoxy-4-iodoamphetamine) is a direct-acting serotonergic 5-HT receptor agonist and induces the head-twitch response (HTR) via stimulation of 5-HT receptor in mice. While more selective serotonin releasers such as d-fenfluramine evoke the HTR, monoamine reuptake blockers (e.g., cocaine) suppress the DOI-evoked HTR via indirect stimulation of serotonergic 5-HT- and adrenergic ɑ-receptors. Since the induction of HTR by DOI is age-dependent, we investigated whether: (1) during development MA can evoke the HTR by itself, and (2) acute pretreatment with either the selective 5-HT receptor antagonist EMD 281014 or low-doses of MA can: (i) modulate the DOI-induced HTR in mice across postnatal days 20, 30 and 60, and (ii) alter the DOI-induced c-fos expression in mice prefrontal cortex (PFC). To further explore the possible modulatory effect of MA on DOI-induced HTR, we investigated whether blockade of inhibitory serotonergic 5-HT- or adrenergic ɑ-receptors by corresponding selective antagonists (WAY 100635 or RS 79948, respectively), can prevent the effect of MA on DOI-induced HTR during aging.
Although neither EMD 281014 nor MA by themselves could evoke the HTR, acute pretreatment with either EMD 281014 (0.01, 0.05 and 0.1 mg/kg, i.p.) or MA (1, 2.5, 5 mg/kg, i.p.), dose-dependently suppressed the DOI-induced HTR across ages. While WAY 100635 significantly reversed the inhibitory effect of MA in 20- and 30-day old mice, RS 79948 failed to significantly counter MA's inhibitory effect. Moreover, DOI significantly increased c-fos expressions in several PFC regions. EMD 281014 prevented the DOI-induced increases in c-fos expression. Despite the inhibitory effect of MA on DOI-induced HTR, MA alone or in combination with DOI, significantly increased c-fos expression in several regions of the PFC.
The suppressive effect of MA on the DOI-evoked HTR appears to be mainly due to functional interactions between the HTR-inducing 5-HT receptor and the inhibitory 5-HT receptor. The MA-induced increase in c-fos expression in different PFC regions may be due to MA-evoked increases in synaptic concentrations of 5-HT, NE and/or DA.
甲基苯丙胺(MA)是非选择性单胺释放剂,因此会从相应的神经末梢将 5-羟色胺(5-HT)、去甲肾上腺素(NE)和多巴胺(DA)释放到突触中。DOI((±)-2,5-二甲氧基-4-碘苯丙胺)是一种直接作用的血清素 5-HT 受体激动剂,通过刺激小鼠的 5-HT 受体诱导头部抽搐反应(HTR)。虽然更具选择性的血清素释放剂,如 d-芬氟拉明,会引起 HTR,但单胺再摄取抑制剂(如可卡因)通过间接刺激 5-HT 和肾上腺素能α受体抑制 DOI 诱导的 HTR。由于 DOI 诱导的 HTR 与年龄有关,我们研究了以下问题:(1)在发育过程中,MA 是否可以自行引起 HTR;(2)急性预用选择性 5-HT 受体拮抗剂 EMD 281014 或 MA 低剂量是否可以:(i)调节 20、30 和 60 天龄小鼠 DOI 诱导的 HTR;(ii)改变 20、30 和 60 天龄小鼠前额叶皮层(PFC)中 DOI 诱导的 c-fos 表达。为了进一步探索 MA 对 DOI 诱导的 HTR 可能的调节作用,我们研究了相应选择性拮抗剂(WAY 100635 或 RS 79948,分别为抑制性血清素 5-HT 或肾上腺素能α受体)是否可以阻止 MA 在衰老过程中对 DOI 诱导的 HTR 的影响。
尽管 EMD 281014 或 MA 本身均不能引起 HTR,但急性预用 EMD 281014(0.01、0.05 和 0.1mg/kg,ip)或 MA(1、2.5、5mg/kg,ip)均可剂量依赖性地抑制各年龄段的 DOI 诱导的 HTR。虽然 WAY 100635 显著逆转了 20 天和 30 天龄小鼠中 MA 的抑制作用,但 RS 79948 未能显著拮抗 MA 的抑制作用。此外,DOI 显著增加了 PFC 中几个区域的 c-fos 表达。EMD 281014 阻止了 DOI 诱导的 c-fos 表达增加。尽管 MA 对 DOI 诱导的 HTR 有抑制作用,但 MA 单独或与 DOI 联合使用时,可显著增加 PFC 中几个区域的 c-fos 表达。
MA 对 DOI 诱导的 HTR 的抑制作用似乎主要归因于诱导 HTR 的 5-HT 受体和抑制性 5-HT 受体之间的功能相互作用。MA 在前额叶皮层不同区域引起的 c-fos 表达增加可能是由于 MA 引起的 5-HT、去甲肾上腺素和/或多巴胺突触浓度增加所致。